PharmaLundensis
0,35 SEK
+17,67 %
Mindre end 1K følgere
PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
+17,67 %
+43,50 %
-1,94 %
-31,85 %
-1,12 %
-51,89 %
-51,78 %
-56,39 %
-89,24 %
PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.
Læs mereMarkedsværdi
21,18 mio. SEK
Aktieomsætning
19,62 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
19.2
2026
Årsrapport '25